Venenum Bio Design
Biotechnology, 8 Black FRST Rd, Hamilton, New Jersey, 08691, United States, 11-50 Employees
Phone Number: 87********
Who is VENENUM BIODESIGN
VENENUM Biodesign, a Genesis Drug Discovery and Development (GD3) Company, is focused on discovering and advancing innovative new medicines for significant unmet medical needs in key ther...
Read More
-
Headquarters: 8 Black FRST Rd, Hamilton, New Jersey, 08691, United States
-
Date Founded: 2009
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 5169
|
NAICS Code: 424690 |
Show More
Does something look wrong? Fix it. | View contact records from VENENUM BIODESIGN
Venenum BioDesign Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Venenum BioDesign
Answer: Venenum BioDesign's headquarters are located at 8 Black FRST Rd, Hamilton, New Jersey, 08691, United States
Answer: Venenum BioDesign's phone number is 87********
Answer: Venenum BioDesign's official website is https://venenumbiodesign.com
Answer: Venenum BioDesign's revenue is $10 Million to $25 Million
Answer: Venenum BioDesign's SIC: 5169
Answer: Venenum BioDesign's NAICS: 424690
Answer: Venenum BioDesign has 11-50 employees
Answer: Venenum BioDesign is in Biotechnology
Answer: Venenum BioDesign contact info: Phone number: 87******** Website: https://venenumbiodesign.com
Answer: VENENUM Biodesign, a Genesis Drug Discovery and Development (GD3) Company, is focused on discovering and advancing innovative new medicines for significant unmet medical needs in key therapeutic areas, including; cancer, inflammation, infectious diseases, metabolic diseases, and womens health. Our most advanced programs are targeting Clostridium difficile infection (CDI) and Type 2 Diabetes (T2D). Our business model allows us to focus on the creation of high value, innovative small molecule programs against well-validated targets, as well as new targets identified from our own research and to work with partners for clinical and commercial development to bring our products to patients. Our mission is to improve patients lives through the discovery of therapeutic compounds against our novel biological targets. Many of our targets involve novel protein-protein or protein-DNA interactions. Others are more conventional target classes e.g., GPCRs and enzymes. Our goal is to advance our discoveries to medicine through partnership with pharmaceutical companies. We utilize state-of-the-art assay development and ultra-high throughput screening (UHTS) against our proprietary 6 million ECLiPS compound collection in conjunction with protein engineering and structural biology, medicinal chemistry, and in vivo models.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month